PDCD1 and neoplasm: In vivo efficacy and PD biomarkers induced by anti-PD-1–GITR-L in mice were validated with the human bispecific in humanized single-target KI and NSG allogeneic PBMC-engrafted mouse tumor models, which supports translation of the MoA.